In conjunction with previous findings, the present study indicated that ibudilast administration effectively blocked the pro-inflammatory response by downregulating the TLR4/NF-κB-mediated pathway and inhibiting NLRP3 inflammasome activation in an FA-induced AKI model. Here, NFKB1 is linked to acute kidney injury.